TrialThe Lancet. Infectious diseases2012

Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.

Steven J Reynolds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.